A MULTICENTER, PHASE 1B, OPEN LABEL, NONRANDOMIZED, SINGLE DOSE STUDY EVALUATING THE SAFETY, TOLERABILITY AND ACTIVITY OF BIVV020 IN ADULTS WITH COLD AGGLUTININ DISEASE

Registry ID

PDY16370

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

SANOFI-AVENTIS CANADA INC

Start date

2021-03-17

Last update

2020-02-11

Conditions

• COLD AGGLUTININ DISEASE

Related clinical trials

• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF BIVV009 IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE WITHOUT A RECENT HISTORY OF BLOOD TRANSFUSION

View on source registry